GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 13401 - 13450 of 40384 in total
PDB ID UniProt ID Title ▲ Descriptor
6W41 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
6W41 6W41 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
7S5R P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
7S5R 7S5R Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
8GB7 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7
8GB7 8GB7 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7
8GB6 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6
8GB6 8GB6 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6
8GB5 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9
8GB5 8GB5 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9
7MF1 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
7MF1 7MF1 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
7U2D P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20
7U2D 7U2D Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20
7U2E P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
7U2E 7U2E Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
6XC2 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
6XC2 6XC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
6XC4 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
6XC4 6XC4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
8SDF P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4
8SDF 8SDF Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4
8SDG 8SDG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43
8SDG P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43
8SDH P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56
8SDH 8SDH Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56
7JMO P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
7JMO 7JMO Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
9B82 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15
9B82 9B82 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15
7JMP P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
7JMP 7JMP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
6XKQ P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
6XKQ 6XKQ Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
6XKP P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
6XKP 6XKP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
7TP4 7TP4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
7TP4 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
8FI9 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5001
8FI9 8FI9 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5001
8EOO 8EOO Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151
8EOO P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151
7N4I P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.
7N4I 7N4I Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.
7N4M P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.
7N4M 7N4M Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.
7N4J P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.
7N4J 7N4J Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.
7FBJ P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
7FBJ 7FBJ Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024